US Edition
Published • loading... • Updated
Biotech Growth rebounds 77% since April lows and its board still thinks the shares are cheap
Summary by QuotedData
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Biotech Growth rebounds 77% since April lows and its board still thinks the shares are cheap
Biotech Growth (BIOG) is ploughing on with share buybacks in the hope investors will soon sit up and notice the startling recovery in its shares. Since early April, when the investment trust had tumbled to more than a six-year low on Trump tariff fears, the shares have shot up 77%, lifting its market valuation to […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
